The relationship between BMI change and diagnosis of pancreatic cancer in patients with diabetes worsening

The relationship between BMI change and diagnosis of pancreatic cancer in patients with diabetes worsening - Diagnostic strategy of pancreatic cancer in DM worsening

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028991

Enrollment

250

Registered

2017-11-01

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) age: more than 20 years old (2) type 2 diabetes patients (3) elevation of HbA1c (more than 0.5%) without drug change (4) agree to participate this study

Exclusion criteria

Exclusion criteria: (1) steroid use (2) diseases which are likely to elevate blood glucose

Design outcomes

Primary

Measure	Time frame
To investigate the diagnosis rate of pancreatic cancer according to the degree of BMI change	—

Secondary

Measure	Time frame
To compare the diagnostic rate of gastric cancer or colon cancer	—

Countries

Japan

Contacts

Public ContactNoriko Inomata

Kobe Graduate School of Medicine Division of Gastroenterology, Department of Internal Medicine

inomat@med.kobe-u.ac.jp078-382-6305

Outcome results